{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T03:37:58Z","timestamp":1790393878914,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00415-026-13858-2","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:07:37Z","timestamp":1779448057000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Late-onset multiple sclerosis is associated with relapse-independent disability accrual: a propensity score-weighted recurrent-event study"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3779-0934","authenticated-orcid":false,"given":"Andrea","family":"Surcinelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Panzera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Piscaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Zagnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Rossetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Mancinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Ganino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Masullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriana","family":"Nanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Lugaresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0321-7155","authenticated-orcid":false,"given":"Matteo","family":"Foschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"13858_CR1","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1001\/jamaneurol.2024.3062","volume":"81","author":"LH Hua","year":"2024","unstructured":"Hua LH, Solomon AJ, Tenembaum S, Scalfari A, Rovira \u00c0, Rostasy K et al (2024) Differential diagnosis of suspected multiple sclerosis in pediatric and late-onset populations: a review. JAMA Neurol 81:1210. https:\/\/doi.org\/10.1001\/jamaneurol.2024.3062","journal-title":"JAMA Neurol"},{"key":"13858_CR2","doi-asserted-by":"publisher","first-page":"29649","DOI":"10.1038\/s41598-024-81284-3","volume":"14","author":"CE Cicero","year":"2024","unstructured":"Cicero CE, Chisari C, Salafica G, Lo Fermo S, Donzuso G, Maimone D et al (2024) Incidence of late onset multiple sclerosis in Italy: a population-based study. Sci Rep 14:29649. https:\/\/doi.org\/10.1038\/s41598-024-81284-3","journal-title":"Sci Rep"},{"key":"13858_CR3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ana.26843","volume":"95","author":"S Knowles","year":"2024","unstructured":"Knowles S, Middleton R, Cooze B, Farkas I, Leung YY, Allen K et al (2024) Comparing the pathology, clinical, and demographic characteristics of younger and older\u2010onset multiple sclerosis. Ann Neurol 95:471\u2013486. https:\/\/doi.org\/10.1002\/ana.26843","journal-title":"Ann Neurol"},{"key":"13858_CR4","doi-asserted-by":"publisher","first-page":"e208051","DOI":"10.1212\/WNL.0000000000208051","volume":"102","author":"EF Mouresan","year":"2024","unstructured":"Mouresan EF, Mentesidou E, Berglund A, McKay KA, Hillert J, Iacobaeus E (2024) Clinical characteristics and long-term outcomes of late-onset multiple sclerosis: a Swedish nationwide study. Neurology 102:e208051. https:\/\/doi.org\/10.1212\/WNL.0000000000208051","journal-title":"Neurology"},{"key":"13858_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-12152-9","author":"L Lorefice","year":"2024","unstructured":"Lorefice L, Ferraro OE, Fenu G, Amato MP, Bresciamorra V, Conte A et al (2024) Late-onset multiple sclerosis: disability trajectories in relapsing\u2013remitting patients of the Italian MS registry. J Neurol. https:\/\/doi.org\/10.1007\/s00415-023-12152-9","journal-title":"J Neurol"},{"key":"13858_CR6","doi-asserted-by":"publisher","first-page":"e0005","DOI":"10.1212\/WN9.0000000000000005","volume":"1","author":"S Ziccardi","year":"2025","unstructured":"Ziccardi S, Fuchs TA, Guandalini M, Marastoni D, Benedict RHB, Calabrese M (2025) Cognitive progression independent of relapse and MRI activity in multiple sclerosis. Neurol Open Access 1:e0005. https:\/\/doi.org\/10.1212\/WN9.0000000000000005","journal-title":"Neurol Open Access"},{"key":"13858_CR7","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1001\/jamaneurol.2020.1568","volume":"77","author":"L Kappos","year":"2020","unstructured":"Kappos L, Wolinsky JS, Giovannoni G, Arnold DL, Wang Q, Bernasconi C et al (2020) Contribution of relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled analysis of 2 randomized clinical trials. JAMA Neurol 77:1132. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1568","journal-title":"JAMA Neurol"},{"key":"13858_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00415-025-13581-4","volume":"273","author":"A Surcinelli","year":"2026","unstructured":"Surcinelli A, Massa I, Gentili N, Panzera I, Malag\u00f9 S, Mancinelli L et al (2026) Harmonized magnetic resonance imaging protocols for multiple sclerosis: HARMONY-MS, a pilot project. J Neurol 273:39. https:\/\/doi.org\/10.1007\/s00415-025-13581-4","journal-title":"J Neurol"},{"key":"13858_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res 46:399\u2013424. https:\/\/doi.org\/10.1080\/00273171.2011.568786","journal-title":"Multivar Behav Res"},{"key":"13858_CR10","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1176345976","author":"PK Andersen","year":"1982","unstructured":"Andersen PK, Gill RD (1982) Cox\u2019s regression model for counting processes: a large sample study. Ann Stat. https:\/\/doi.org\/10.1214\/aos\/1176345976","journal-title":"Ann Stat"},{"key":"13858_CR11","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1007\/s00415-024-12448-4","volume":"271","author":"E Portaccio","year":"2024","unstructured":"Portaccio E, Betti M, De Meo E, Addazio I, Past\u00f2 L, Razzolini L et al (2024) Progression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression. J Neurol 271:5074\u20135082. https:\/\/doi.org\/10.1007\/s00415-024-12448-4","journal-title":"J Neurol"},{"key":"13858_CR12","doi-asserted-by":"publisher","first-page":"e207936","DOI":"10.1212\/WNL.0000000000207936","volume":"102","author":"C Tur","year":"2024","unstructured":"Tur C, Rocca MA (2024) Progression independent of relapse activity in multiple sclerosis: closer to solving the pathologic puzzle. Neurology 102:e207936. https:\/\/doi.org\/10.1212\/WNL.0000000000207936","journal-title":"Neurology"},{"key":"13858_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1001\/jamaneurol.2022.5250","volume":"80","author":"S Meier","year":"2023","unstructured":"Meier S, Willemse EAJ, Schaedelin S, Oechtering J, Lorscheider J, Melie-Garcia L et al (2023) Serum glial fibrillary acidic protein compared with neurofilament light chain as a biomarker for disease progression in multiple sclerosis. JAMA Neurol 80:287. https:\/\/doi.org\/10.1001\/jamaneurol.2022.5250","journal-title":"JAMA Neurol"},{"key":"13858_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s00415-025-13093-1","volume":"272","author":"MS Freedman","year":"2025","unstructured":"Freedman MS, Abdelhak A, Bhutani MK, Freeman J, Gnanapavan S, Hussain S et al (2025) The role of serum neurofilament light (sNfL) as a biomarker in multiple sclerosis: insights from a systematic review. J Neurol 272:400. https:\/\/doi.org\/10.1007\/s00415-025-13093-1","journal-title":"J Neurol"},{"key":"13858_CR15","doi-asserted-by":"publisher","first-page":"175628642413066","DOI":"10.1177\/17562864241306684","volume":"17","author":"A Dal-Bianco","year":"2024","unstructured":"Dal-Bianco A, Oh J, Sati P, Absinta M (2024) Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance. Ther Adv Neurol Disord 17:17562864241306684. https:\/\/doi.org\/10.1177\/17562864241306684","journal-title":"Ther Adv Neurol Disord"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13858-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13858-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13858-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T17:09:48Z","timestamp":1781370588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13858-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["13858"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13858-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest related to the content of this study. They note, however, that patients included in the analysis received various disease-modifying therapies, and some authors have received honoraria, travel grants, consulting fees, research support, or participated in advisory boards sponsored by pharmaceutical companies, including Actelion, Allergan, Almirall, Alexion, Amgen, Bayer Schering, Biogen, Bristol Myers Squibb, Celgene, Excemed, Genzyme, Forward Pharma, Ipsen, Medday, Merck, Mylan, Novartis, Sanofi, Roche, Teva, and their affiliates. These relationships had no influence on the design, analysis, or interpretation of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The RMSR received ethical approval from the local ethical committee (Comitato Etico della Romagna\u2014CEROM) on date 05\/11\/2021 (approval code: 3139). All participants gave written informed consent to be enrolled in the RMSR according to the Declaration of Helsinki, 1964.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"332"}}